Vinergy Resources/MJ BioPharma to Acquire 65% of Health Canada and FDA Licensed Laboratory to Pursue Drug Testing and Dosage of CBDs, THC and Terpenes

VANCOUVER, BRITISH COLUMBIA, VNNYF, (Marketwired Feb 22, 2017) Vinergy Resources Ltd. ( Vinergy or the Company ) (CSE:VIN)(OTCQB:VNNYF) in conjunction with its proposed acquisition of MJ BioPharma (announced December 14, 2016) is pleased to announce that, as a part of the Company s strategy to develop products that test and identify specific cannabinoid isolates for targeted therapeutic purposes it has signed a binding Letter of Intent ( LOI ) to acquire 65% of Biolennia Laboratories Inc. (the Laboratory ). Biolennia will provide a host of
http://bit.ly/2kMgKhz